Answer
No clinical data on exposed pregnancies are available for Sugammadex; animal studies indicate no direct or indirect harmful effects on pregnancy, embryonic/foetal development, childbirth or postnatal development, but caution is advised when administering it to pregnant women.
Sources for this answer
- Sugammadex 100 mg/mL solution for injectionGlenmark Pharmaceuticals Europe Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 2Document updated
Sources checked